FSGS - ETF AI Analysis

Top Page

Small Cap US Equity Select ETF (FSGS)

Rating:74Outperform

Price Target:―

FSGS, the Small Cap US Equity Select ETF, has a solid overall rating driven mainly by strong, profitable companies like Catalyst Pharma and Alkermes, which show healthy financial performance, strategic growth moves, and generally positive outlooks. Other holdings such as Deckers Outdoor, Rambus, and Napco Security Technologies also support the fund with good earnings and growth prospects, though some face valuation concerns and mixed technical signals. The main risk is that several holdings show signs of high valuations or technical caution, which could make the fund more sensitive to market pullbacks.

Positive Factors

Broad Sector Diversification

The fund spreads its investments across many sectors, which can help reduce the impact if any one industry struggles.

Strong Top Holdings Performance

Several of the largest positions, such as Rambus and other leading names, have shown strong gains so far this year, supporting the ETF’s overall results.

Positive Recent Performance

The ETF has delivered steady gains over the year-to-date, three-month, and one-month periods, indicating recent upward momentum.

Negative Factors

High Expense Ratio

The fund’s expense ratio is relatively high for an ETF, which means more of the returns are eaten up by fees over time.

Small Asset Base

With a relatively low level of assets under management, the fund may be less liquid and more vulnerable to large investor inflows or outflows.

Concentrated U.S. Exposure

Almost all of the ETF’s holdings are in U.S. companies, offering little geographic diversification if the U.S. market faces a downturn.

FSGS vs. SPDR S&P 500 ETF (SPY)

AUM28.58M

RegionNorth America

Expense Ratio0.60%

Beta0.87

IssuerFirst Trust

Inception DateJun 20, 2017

Dividend YieldN/A

Asset ClassEquity

Index TrackedSMID Growth Strength Index - Benchmark TR Gross

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume6,304

30 Day Avg. Volume2,609

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

37.30

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering100

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

FSGS Summary

FSGS is the Small Cap US Equity Select ETF, which follows the SMID Growth Strength Index. It focuses on smaller U.S. companies that are aiming for growth, across areas like technology, industrials, finance, and health care. Examples of companies it holds include Rambus and Interactive Brokers. Someone might invest in this ETF to seek long-term growth and to diversify beyond large, well-known stocks by adding a wide mix of smaller, more agile businesses. A key risk is that small-cap stocks can be more volatile, so the ETF’s price can move up and down more sharply than the overall market.

How much will it cost me?The Small Cap US Equity Select ETF (Ticker: FSGS) has an expense ratio of 0.6%, which means you’ll pay $6 per year for every $1,000 invested. This is higher than average because the ETF is actively managed, focusing on small-cap companies with growth potential, which requires more research and management effort.

What would affect this ETF?The Small Cap US Equity Select ETF (FSGS) could benefit from economic growth and innovation in the U.S., particularly in technology and financial sectors, which are its largest exposures. However, it may face challenges from rising interest rates or economic slowdowns, which can negatively impact small-cap companies and growth-focused investments. Regulatory changes or sector-specific disruptions could also influence the performance of its top holdings.

FSGS Top 10 Holdings

FSGS leans into U.S. small caps with a clear tilt toward growth stories, and several of its top names are pulling their weight. Rambus is one of the main engines, riding the AI and chip momentum, while Cactus and Weatherford give the fund an extra boost from a firm energy and industrial backdrop. Interactive Brokers is quietly steady, adding financial strength in the background. On the softer side, Catalyst Pharma has been more mixed lately, occasionally losing steam and modestly dampening overall results, but not enough to derail the fund’s broadly rising trend.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
STRL	Sterling Infrastructure	1.31%	$379.11K	$13.45B	230.64%	71 Outperform
LRN	Stride	1.28%	$368.08K	$3.61B	-39.45%	70 Outperform
WFRD	Weatherford International	1.27%	$365.52K	$7.27B	43.78%	72 Outperform
FIX	Comfort Systems	1.25%	$359.91K	$47.19B	241.99%	80 Outperform
ENSG	The Ensign Group	1.24%	$357.77K	$12.40B	66.66%	78 Outperform
ATI	ATI	1.21%	$350.18K	$19.55B	135.80%	78 Outperform
DECK	Deckers Outdoor	1.21%	$349.16K	$16.43B	-25.37%	79 Outperform
WWD	Woodward	1.20%	$347.14K	$22.62B	103.39%	79 Outperform
EME	EMCOR Group	1.20%	$345.95K	$35.85B	87.86%	73 Outperform
NSSC	Napco Security Technologies	1.20%	$345.39K	$1.57B	72.12%	80 Outperform

FSGS Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

31.08

Negative

100DMA

30.89

Negative

200DMA

30.49

Negative

Market Momentum

MACD

-0.22

Positive

RSI

40.59

Neutral

STOCH

16.39

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FSGS, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 31.13, equal to the 50-day MA of 31.08, and equal to the 200-day MA of 30.49, indicating a bearish trend. The MACD of -0.22 indicates Positive momentum. The RSI at 40.59 is Neutral, neither overbought nor oversold. The STOCH value of 16.39 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FSGS.

FSGS Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
FSGS	―	―	$28.58M	0.60%	―
OASC	―	―	$72.72M	0.69%	―
FSCS	―	―	$61.33M	0.60%	―
SMOX	―	―	$55.80M	0.75%	―
ASCE	―	―	$45.65M	0.38%	―
NIXT	―	―	$34.94M	0.19%	―

Performance Comparison

FSGS

Small Cap US Equity Select ETF

30.35

0.30

1.00%

OASC

OneAscent Small Cap Core ETF

―

FSCS

First Trust Smid Capital Strength Etf

―

SMOX

Horizon Small/Mid Cap Core Equity ETF

―

ASCE

Allspring SMID Core ETF

―

NIXT

Research Affiliates Deletions ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents